Syapse, Inc., A Precision Medicine Company Entered Into Collaboration With Roche For Precision Medicine Diagnostics Market

Precision Medicine Diagnostics Market

 Growing initiatives by the government to raise awareness regarding precision medicine is driving the growth of the precision medicine diagnostics market. For instance, in March 2018, the Division of Community Engagement and University of Agricultural and Horticultural Sciences (UAHS) Center for Applied Genetics and Genomic Medicine partnered with the University Of Arizona Banner Health Research Program to develop and implement a unique and culturally conscious approach to increase precision medicine literacy, particularly among underserved and marginalized populations. The program has been named ‘Precision Medicine Community Health Workers/Promoters for All of Us’. Moreover, an increasing partnership among key players to develop cancer therapy is again fostering the growth of the market. For instance, in October 2017, the National Institutes of Health (NIH) collaborated with 11 biopharmaceutical companies to launch a five-year Accelerating Cancer Therapies (PACT) program, this collaboration is focused on enhancing precision medicine approaches to cancer care.

  1. In May 2019, QIAGEN N.V., launched PIK3CA RGQ PCR biomarker to enhance precision medicine in the breast cancer patient

  2. In January 2018, Syapse collaborated with Roche to advance precision medicine in oncology. Also, this partnership focuses on clinical delivery and product development for introducing precision medicine

  3. In February 2019, ICON plc, a drug development solution provider and service acquired Molecular MD for the development and commercialization of precision medicines in oncology

  4. In 2018, Syapse, Inc., a precision medicine company entered into collaboration with Roche to make precision medicine for cancer patients

  5. In 2018, Konica Minolta Inc. launched Konica Minolta precision medicine in Japan

North America is expected to gain the fastest growth in the global precision medicine diagnostics market in the near future. This is attributed to the high prevalence of cancer and growing initiatives by key players to develop precision medicine diagnostics for cancer. According to the National Institutes of Health, prostate, lung, and colorectal cancers account for an estimated 43% of all cancers diagnosed in men in 2020. For women, the three most common cancers are breast, lung, and colorectal, and they account for an estimated 50% of all new cancer diagnoses in women in 2020.

Precision medicine is basically based on the theory that every aspect of the human body is individual and might not respond the same way to a certain medical intervention. While much of today's pharmaceutical manufacturing is geared towards drugs that help millions of chronic patients, improvements in the medical and drug industry are also leading to greater precision medical procedures.

Comments

Popular posts from this blog

Growing The Production And Sales Of Racing Cars And High-Performance Vehicles To Boost The Automotive Roller Tappets Market

Medium Voltage Vacuum Contactors Market Report, Shares, Global Opportunity Analysis and Industry Forecast

The Global Achondroplasia Treatment Market Is Witnessing High Demand Owing To the Rise of the Condition and the Focus of the Key Market Players on Discovering Advanced Medical Technologies